This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Meglumine is an amino sugar found in iodinated contrast media.

Generic Name
Meglumine
DrugBank Accession Number
DB09415
Background

Not Available

Type
Small Molecule
Groups
Approved
Structure
Weight
Average: 195.215
Monoisotopic: 195.110672651
Chemical Formula
C7H17NO5
Synonyms
  • 1-deoxy-1-methylaminosorbitol
  • Iosulamide
  • Meglumina
  • Méglumine
  • Meglumine
  • Megluminum
  • N-methyl-D-glucamine
External IDs
  • NSC-52907
  • NSC-7391

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Methylglucamine hydrochloride2IG86HL9XM35564-86-4PKPZZAVJXDZHDW-LJTMIZJLSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
UROGRAFIN %76, 100 MLMeglumine (660 mg/ml) + Diatrizoate sodium (100 mg/ml)SolutionIntravascularBAYER TÜRK KİMYA SAN. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
UROGRAFIN %76, 50 MLMeglumine (660 mg/ml) + Diatrizoate sodium (100 mg/ml)SolutionIntravascularBAYER TÜRK KİMYA SAN. LTD. ŞTİ.2020-08-14Not applicableTurkey flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbohydrates and carbohydrate conjugates
Direct Parent
Hexoses
Alternative Parents
1,3-aminoalcohols / Secondary alcohols / 1,2-aminoalcohols / Polyols / Dialkylamines / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
1,2-aminoalcohol / 1,3-aminoalcohol / Alcohol / Aliphatic acyclic compound / Amine / Hexose monosaccharide / Hydrocarbon derivative / Organic nitrogen compound / Organonitrogen compound / Organopnictogen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
secondary amino compound, hexosamine (CHEBI:59732)
Affected organisms
Not Available

Chemical Identifiers

UNII
6HG8UB2MUY
CAS number
6284-40-8
InChI Key
MBBZMMPHUWSWHV-BDVNFPICSA-N
InChI
InChI=1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
IUPAC Name
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

References

General References
Not Available
Human Metabolome Database
HMDB0240291
KEGG Drug
D01796
ChemSpider
8249
RxNav
6704
ChEBI
59732
ChEMBL
CHEMBL1200570
ZINC
ZINC000002020259
Wikipedia
Meglumine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic SciencePharmacokinetics1
4CompletedDiagnosticAllergic Reaction1
4CompletedTreatmentStroke, Ischemic2
4RecruitingSupportive CareNephrogenic Fibrosing Dermopathy1
3CompletedTreatmentCognitive Dysfunctions1
2RecruitingTreatmentMetabolic Acidosis1
2Unknown StatusTreatmentStroke, Ischemic1
2, 3Unknown StatusTreatmentStroke, Ischemic1
1WithdrawnTreatmentSafety1
0RecruitingDiagnosticHeart Failure / Left Ventricular Hypertrophy / Myocardial Infarction1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionParenteral
SolutionIntravascular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility240.0 mg/mLALOGPS
logP-2.4ALOGPS
logP-3.4ChemAxon
logS0.09ALOGPS
pKa (Strongest Acidic)12.65ChemAxon
pKa (Strongest Basic)9.11ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area113.18 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity44.84 m3·mol-1ChemAxon
Polarizability19.66 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - EI-BGC-MSsplash10-0006-9100000000-e892e9e9fcffcbf59eaa
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created at November 30, 2015 19:10 / Updated at May 21, 2021 10:21